{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:54:40Z","timestamp":1794588880302,"version":"4.9.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple system atrophy (MSA) is a neurodegenerative disease with diverse clinical manifestations, including parkinsonism, cerebellar syndrome, and autonomic failure. Pathologically, MSA is characterized by glial cytoplasmic inclusions in oligodendrocytes, which contain fibrillary forms of \u03b1-synuclein. MSA is categorized as one of the \u03b1-synucleinopathy, and \u03b1-synuclein aggregation is thought to be the culprit of the disease pathogenesis. Studies on MSA pathogenesis are scarce relative to studies on the pathogenesis of other synucleinopathies, such as Parkinson\u2019s disease and dementia with Lewy bodies. However, recent developments in cellular and animal models of MSA, especially \u03b1-synuclein transgenic models, have driven advancements in research on this disease. Here, we review the currently available models of MSA, which include toxicant-induced animal models, \u03b1-synuclein-overexpressing cellular models, and mouse models that express \u03b1-synuclein specifically in oligodendrocytes through cell type-specific promoters. We will also discuss the results of studies in recently developed transmission mouse models, into which MSA brain extracts were intracerebrally injected. By reviewing the findings obtained from these model systems, we will discuss what we have learned about the disease and describe the strengths and limitations of the models, thereby ultimately providing direction for the design of better models and future research.<\/jats:p>","DOI":"10.1038\/s12276-019-0346-8","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T19:02:10Z","timestamp":1575399730000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Models of multiple system atrophy"],"prefix":"10.1038","volume":"51","author":[{"given":"He-Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diadem","family":"Ricarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"346_CR1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jnnp.32.1.28","volume":"32","author":"JG Graham","year":"1969","unstructured":"Graham, J. G. & Oppenheimer, D. R. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 32, 28\u201334 (1969).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"346_CR2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag, A., Ben-Shlomo, Y. & Quinn, N. P. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354, 1771\u20131775 (1999).","journal-title":"Lancet"},{"key":"346_CR3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/WNL.48.2.384","volume":"48","author":"Y Ben-Shlomo","year":"1997","unstructured":"Ben-Shlomo, Y., Wenning, G. K., Tison, F. & Quinn, N. P. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 48, 384\u2013393 (1997).","journal-title":"Neurology"},{"key":"346_CR4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00702-007-0746-0","volume":"114","author":"U Wullner","year":"2007","unstructured":"Wullner, U. et al. Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson\u2019s disease. J. Neural Transm. 114, 1161\u20131165 (2007).","journal-title":"J. Neural Transm."},{"key":"346_CR5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.21839","volume":"23","author":"A Schrag","year":"2008","unstructured":"Schrag, A., Wenning, G. K., Quinn, N. & Ben-Shlomo, Y. Survival in multiple system atrophy. Mov. Disord. 23, 294\u2013296 (2008).","journal-title":"Mov. Disord."},{"key":"346_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli, A. & Wenning, G. K. Multiple-system atrophy. N. Engl. J. Med. 372, 249\u2013263 (2015).","journal-title":"N. Engl. J. Med"},{"key":"346_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","volume":"11","author":"M Jecmenica-Lukic","year":"2012","unstructured":"Jecmenica-Lukic, M., Poewe, W., Tolosa, E. & Wenning, G. K. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol. 11, 361\u2013368 (2012).","journal-title":"Lancet Neurol."},{"key":"346_CR8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/mds.20450","volume":"20","author":"LM Benrud-Larson","year":"2005","unstructured":"Benrud-Larson, L. M., Sandroni, P., Schrag, A. & Low, P. A. Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov. Disord. 20, 951\u2013957 (2005).","journal-title":"Mov. Disord."},{"key":"346_CR9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(12)70327-7","volume":"12","author":"GK Wenning","year":"2013","unstructured":"Wenning, G. K. et al. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. 12, 264\u2013274 (2013).","journal-title":"Lancet Neurol."},{"key":"346_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2006.05.064","volume":"249","author":"I Yabe","year":"2006","unstructured":"Yabe, I. et al. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J. Neurol. Sci. 249, 115\u2013121 (2006).","journal-title":"J. Neurol. Sci."},{"key":"346_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autneu.2017.11.002","volume":"211","author":"E Valera","year":"2018","unstructured":"Valera, E. & Masliah, E. The neuropathology of multiple system atrophy and its therapeutic implications. Auton. Neurosci. 211, 1\u20136 (2018).","journal-title":"Auton. Neurosci."},{"key":"346_CR12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.parkreldis.2013.02.012","volume":"19","author":"HJ Kim","year":"2013","unstructured":"Kim, H. J. et al. Clinical and imaging characteristics of dementia in multiple system atrophy. Parkinsonism Relat. Disord. 19, 617\u2013621 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"346_CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14802\/jmd.12010","volume":"5","author":"SW Lee","year":"2012","unstructured":"Lee, S. W. & Koh, S. B. Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy. J. Mov. Disord. 5, 42\u201347 (2012).","journal-title":"J. Mov. Disord."},{"key":"346_CR14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp, M. I., Kahn, J. E. & Lantos, P. L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 94, 79\u2013100 (1989).","journal-title":"J. Neurol. Sci."},{"key":"346_CR15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"346_CR16","doi-asserted-by":"crossref","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa, M. et al. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem. 277, 49071\u201349076 (2002).","journal-title":"J. Biol. Chem."},{"key":"346_CR17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-010-0672-3","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger, K. A. & Lantos, P. L. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol. 119, 657\u2013667 (2010).","journal-title":"Acta Neuropathol."},{"key":"346_CR18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/bies.200900008","volume":"31","author":"J Ovadi","year":"2009","unstructured":"Ovadi, J. & Orosz, F. An unstructured protein with destructive potential: TPPP\/p25 in neurodegeneration. Bioessays 31, 676\u2013686 (2009).","journal-title":"Bioessays"},{"key":"346_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/glia.20909","volume":"58","author":"A Lehotzky","year":"2010","unstructured":"Lehotzky, A. et al. Tubulin polymerization-promoting protein (TPPP\/p25) is critical for oligodendrocyte differentiation. Glia 58, 157\u2013168 (2010).","journal-title":"Glia"},{"key":"346_CR20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","volume":"171","author":"YJ Song","year":"2007","unstructured":"Song, Y. J. et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am. J. Pathol. 171, 1291\u20131303 (2007).","journal-title":"Am. J. Pathol."},{"key":"346_CR21","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1074\/jbc.M410409200","volume":"280","author":"E Lindersson","year":"2005","unstructured":"Lindersson, E. et al. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J. Biol. Chem. 280, 5703\u20135715 (2005).","journal-title":"J. Biol. Chem."},{"key":"346_CR22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger, K. A. Lewy body-related alpha-synucleinopathy in the aged human brain. J. Neural Transm. 111, 1219\u20131235 (2004).","journal-title":"J. Neural Transm."},{"key":"346_CR23","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","volume":"20","author":"H McCann","year":"2014","unstructured":"McCann, H., Stevens, C. H., Cartwright, H. & Halliday, G. M. a-synucleinopathy phenotypes. Parkinsonism Relat. Disord. 20, S62\u2013S67 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"346_CR24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz, S. W. et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol. 65, 610\u2013614 (2009).","journal-title":"Ann. Neurol."},{"key":"346_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","volume":"44","author":"PH Tu","year":"1998","unstructured":"Tu, P. H. et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44, 415\u2013422 (1998).","journal-title":"Ann. Neurol."},{"key":"346_CR26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","volume":"96","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi, K. et al. Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. 96, 445\u2013452 (1998).","journal-title":"Acta Neuropathol."},{"key":"346_CR27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557, 558\u2013563 (2018).","journal-title":"Nature"},{"key":"346_CR28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","volume":"112","author":"DW Miller","year":"2005","unstructured":"Miller, D. W. et al. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J. Neural Transm. 112, 1613\u20131624 (2005).","journal-title":"J. Neural Transm."},{"key":"346_CR29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s004010100367","volume":"102","author":"T Ozawa","year":"2001","unstructured":"Ozawa, T. et al. Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol. 102, 188\u2013190 (2001).","journal-title":"Acta Neuropathol."},{"key":"346_CR30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/glia.22653","volume":"62","author":"YT Asi","year":"2014","unstructured":"Asi, Y. T. et al. Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia 62, 964\u2013970 (2014).","journal-title":"Glia"},{"key":"346_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul, M. et al. Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Rep. 5, 174\u2013184 (2015).","journal-title":"Stem Cell Rep."},{"key":"346_CR32","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/jcmm.13563","volume":"22","author":"E Abati","year":"2018","unstructured":"Abati, E., Di Fonzo, A. & Corti, S. In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells. J. Cell Mol. Med. 22, 2536\u20132546 (2018).","journal-title":"J. Cell Mol. Med"},{"key":"346_CR33","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"H-J Lee","year":"2008","unstructured":"Lee, H.-J. et al. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 40, 1835\u20131849 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"346_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046817","volume":"7","author":"H Kisos","year":"2012","unstructured":"Kisos, H., Pukass, K., Ben-Hur, T., Richter-Landsberg, C. & Sharon, R. Increased neuronal alpha-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling alpha-synucleinopathies. PLoS One 7, e46817 (2012).","journal-title":"PLoS One"},{"key":"346_CR35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2014","unstructured":"Reyes, J. F. et al. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62, 387\u2013398 (2014).","journal-title":"Glia"},{"key":"346_CR36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp.60.1.98","volume":"60","author":"J Schwarz","year":"1996","unstructured":"Schwarz, J. et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 60, 98\u2013101 (1996).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"346_CR37","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","volume":"22","author":"N Stefanova","year":"2007","unstructured":"Stefanova, N. et al. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov. Disord. 22, 2196\u20132203 (2007).","journal-title":"Mov. Disord."},{"key":"346_CR38","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee, H.-J. et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285, 9262\u20139272 (2010).","journal-title":"J. Biol. Chem."},{"key":"346_CR39","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim, C. et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562 (2013).","journal-title":"Nat. Commun."},{"key":"346_CR40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neures.2010.12.020","volume":"69","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti, L., Couch, Y., Richardson, J., Cooper, J. M. & Wood, M. J. Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci. Res. 69, 337\u2013342 (2011).","journal-title":"Neurosci. Res."},{"key":"346_CR41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fncel.2015.00437","volume":"9","author":"BD Vieira","year":"2015","unstructured":"Vieira, B. D., Radford, R. A., Chung, R. S., Guillemin, G. J. & Pountney, D. L. Neuroinflammation in multiple system atrophy: response to and cause of alpha-synuclein aggregation. Front. Cell Neurosci. 9, 437 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"346_CR42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mcn.2015.02.015","volume":"65","author":"R Radford","year":"2015","unstructured":"Radford, R. et al. The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to alpha-synuclein inclusions. Mol. Cell Neurosci. 65, 68\u201381 (2015).","journal-title":"Mol. Cell Neurosci."},{"issue":"12","key":"346_CR43","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3390\/ijms19124129","volume":"19","author":"Dario Valdinocci","year":"2018","unstructured":"Valdinocci, D., et al. Extracellular interactions of alpha-synuclein in multiple system atrophy. Int. J. Mol. Sci. 19, 4129 (2018).","journal-title":"International Journal of Molecular Sciences"},{"key":"346_CR44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-006-0119-z","volume":"112","author":"E Croisier","year":"2006","unstructured":"Croisier, E. & Graeber, M. B. Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol. 112, 517\u2013530 (2006).","journal-title":"Acta Neuropathol."},{"key":"346_CR45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner, L. et al. Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia 61, 349\u2013360 (2013).","journal-title":"Glia"},{"key":"346_CR46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","volume":"25","author":"C Kim","year":"2016","unstructured":"Kim, C., Lee, H. J., Masliah, E. & Lee, S. J. Non-cell-autonomous neurotoxicity of alpha-synuclein through microglial toll-like receptor 2. Exp. Neurobiol. 25, 113\u2013119 (2016).","journal-title":"Exp. Neurobiol."},{"key":"346_CR47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2011.09.044","volume":"211","author":"PO Fernagut","year":"2012","unstructured":"Fernagut, P. O. & Tison, F. Animal models of multiple system atrophy. Neuroscience 211, 77\u201382 (2012).","journal-title":"Neuroscience"},{"key":"346_CR48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0306-4522(00)00171-8","volume":"99","author":"C Scherfler","year":"2000","unstructured":"Scherfler, C. et al. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 99, 43\u201354 (2000).","journal-title":"Neuroscience"},{"key":"346_CR49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainresbull.2005.08.025","volume":"68","author":"Z Puschban","year":"2005","unstructured":"Puschban, Z. et al. Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy. Brain Res. Bull. 68, 54\u201358 (2005).","journal-title":"Brain Res. Bull."},{"key":"346_CR50","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00701-011-1133-z","volume":"154","author":"HH Yoon","year":"2012","unstructured":"Yoon, H. H. et al. Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta Neurochir. 154, 935\u2013940 (2012).","journal-title":"Acta Neurochir."},{"key":"346_CR51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0306-4522(00)00500-5","volume":"102","author":"R Waldner","year":"2001","unstructured":"Waldner, R. et al. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Neuroscience 102, 581\u2013592 (2001).","journal-title":"Neuroscience"},{"key":"346_CR52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0306-4522(02)00401-3","volume":"115","author":"I Ghorayeb","year":"2002","unstructured":"Ghorayeb, I. et al. A \u2018single toxin-double lesion\u2019 rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. Neuroscience 115, 533\u2013546 (2002).","journal-title":"Neuroscience"},{"key":"346_CR53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1531-8257(200005)15:3<531::AID-MDS1017>3.0.CO;2-C","volume":"15","author":"I Ghorayeb","year":"2000","unstructured":"Ghorayeb, I. et al. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. Mov. Disord. 15, 531\u2013536 (2000).","journal-title":"Mov. Disord."},{"key":"346_CR54","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0304-3940(02)01137-0","volume":"335","author":"I Ghorayeb","year":"2002","unstructured":"Ghorayeb, I. et al. Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys. Neurosci. Lett. 335, 34\u201338 (2002).","journal-title":"Neurosci. Lett."},{"key":"346_CR55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","volume":"114","author":"PO Fernagut","year":"2002","unstructured":"Fernagut, P. O. et al. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation. Neuroscience 114, 1005\u20131017 (2002).","journal-title":"Neuroscience"},{"key":"346_CR56","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1179\/016164110X12807570509934","volume":"32","author":"PO Fernagut","year":"2010","unstructured":"Fernagut, P. O., Barraud, Q., Bezard, E., Ghorayeb, I. & Tison, F. Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism. Neurol. Res. 32, 1050\u20131053 (2010).","journal-title":"Neurol. Res."},{"key":"346_CR57","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20540","volume":"20","author":"N Stefanova","year":"2005","unstructured":"Stefanova, N., Reindl, M., Poewe, W. & Wenning, G. K. In vitro models of multiple system atrophy. Mov. Disord. 20, S53\u2013S56 (2005).","journal-title":"Mov. Disord."},{"key":"346_CR58","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1074\/jbc.M809671200","volume":"284","author":"CL Kragh","year":"2009","unstructured":"Kragh, C. L. et al. Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J. Biol. Chem. 284, 10211\u201310222 (2009).","journal-title":"J. Biol. Chem."},{"key":"346_CR59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.nbd.2013.12.002","volume":"63","author":"CL Kragh","year":"2014","unstructured":"Kragh, C. L. et al. Prodegenerative IkappaBalpha expression in oligodendroglial alpha-synuclein models of multiple system atrophy. Neurobiol. Dis. 63, 171\u2013183 (2014).","journal-title":"Neurobiol. Dis."},{"key":"346_CR60","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.neurobiolaging.2014.02.028","volume":"35","author":"VE May","year":"2014","unstructured":"May, V. E. et al. alpha-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy. Neurobiol. Aging 35, 2357\u20132368 (2014).","journal-title":"Neurobiol. Aging"},{"key":"346_CR61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fnmol.2017.00329","volume":"10","author":"E Valera","year":"2017","unstructured":"Valera, E. et al. MicroRNA-101 modulates autophagy and oligodendroglial alpha-synuclein accumulation in multiple system atrophy. Front. Mol. Neurosci. 10, 329 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"346_CR62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","volume":"3","author":"PJ Kahle","year":"2002","unstructured":"Kahle, P. J. et al. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 3, 583\u2013588 (2002).","journal-title":"EMBO Rep."},{"key":"346_CR63","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","volume":"25","author":"CW Shults","year":"2005","unstructured":"Shults, C. W. et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J. Neurosci. 25, 10689\u201310699 (2005).","journal-title":"J. Neurosci."},{"key":"346_CR64","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa, I. et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45, 847\u2013859 (2005).","journal-title":"Neuron"},{"key":"346_CR65","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.27041","volume":"32","author":"F Bassil","year":"2017","unstructured":"Bassil, F. et al. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Mov. Disord. 32, 1230\u20131239 (2017).","journal-title":"Mov. Disord."},{"key":"346_CR66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-017-0451-7","volume":"5","author":"RJ Mandel","year":"2017","unstructured":"Mandel, R. J. et al. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates. Acta Neuropathol. Commun. 5, 47 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"346_CR67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00401-017-1772-0","volume":"135","author":"C Overk","year":"2018","unstructured":"Overk, C. et al. Multiple system atrophy: experimental models and reality. Acta Neuropathol. 135, 33\u201347 (2018).","journal-title":"Acta Neuropathol."},{"key":"346_CR68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova, N. et al. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am. J. Pathol. 166, 869\u2013876 (2005).","journal-title":"Am. J. Pathol."},{"key":"346_CR69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10286-014-0266-6","volume":"25","author":"N Stefanova","year":"2015","unstructured":"Stefanova, N. & Wenning, G. K. Animal models of multiple system atrophy. Clin. Auton. Res. 25, 9\u201317 (2015).","journal-title":"Clin. Auton. Res."},{"key":"346_CR70","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mds.25336","volume":"28","author":"M Boudes","year":"2013","unstructured":"Boudes, M. et al. Bladder dysfunction in a transgenic mouse model of multiple system atrophy. Mov. Disord. 28, 347\u2013355 (2013).","journal-title":"Mov. Disord."},{"key":"346_CR71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.expneurol.2013.02.002","volume":"247","author":"D Kuzdas","year":"2013","unstructured":"Kuzdas, D. et al. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence. Exp. Neurol. 247, 531\u2013536 (2013).","journal-title":"Exp. Neurol."},{"key":"346_CR72","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/mds.25804","volume":"29","author":"O Flabeau","year":"2014","unstructured":"Flabeau, O. et al. Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. Mov. Disord. 29, 388\u2013395 (2014).","journal-title":"Mov. Disord."},{"key":"346_CR73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","volume":"6","author":"V Refolo","year":"2018","unstructured":"Refolo, V. et al. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathol. Commun. 6, 2 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"346_CR74","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/jnr.22089","volume":"87","author":"K Ubhi","year":"2009","unstructured":"Ubhi, K. et al. Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J. Neurosci. Res. 87, 2728\u20132739 (2009).","journal-title":"J. Neurosci. Res."},{"key":"346_CR75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/bpa.12678","volume":"29","author":"A Hoffmann","year":"2019","unstructured":"Hoffmann, A. et al. Oligodendroglial alpha-synucleinopathy-driven neuroinflammation in multiple system atrophy. Brain Pathol. 29, 380\u2013396 (2019).","journal-title":"Brain Pathol."},{"key":"346_CR76","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","volume":"30","author":"K Ubhi","year":"2010","unstructured":"Ubhi, K. et al. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J. Neurosci. 30, 6236\u20136246 (2010).","journal-title":"J. Neurosci."},{"key":"346_CR77","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ejn.12444","volume":"39","author":"K Ubhi","year":"2014","unstructured":"Ubhi, K. et al. Widespread microRNA dysregulation in multiple system atrophy-disease-related alteration in miR-96. Eur. J. Neurosci. 39, 1026\u20131041 (2014).","journal-title":"Eur. J. Neurosci."},{"key":"346_CR78","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2353\/ajpath.2009.080503","volume":"174","author":"K Nakayama","year":"2009","unstructured":"Nakayama, K., Suzuki, Y. & Yazawa, I. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy. Am. J. Pathol. 174, 1471\u20131480 (2009).","journal-title":"Am. J. Pathol."},{"key":"346_CR79","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bbrc.2011.12.092","volume":"417","author":"K Nakayama","year":"2012","unstructured":"Nakayama, K., Suzuki, Y. & Yazawa, I. Binding of neuronal alpha-synuclein to beta-III tubulin and accumulation in a model of multiple system atrophy. Biochem. Biophys. Res. Commun. 417, 1170\u20131175 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"346_CR80","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2012.10.057","volume":"428","author":"H Ito","year":"2012","unstructured":"Ito, H., Nakayama, K., Jin, C., Suzuki, Y. & Yazawa, I. alpha-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy. Biochem. Biophys. Res. Commun. 428, 348\u2013353 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"346_CR81","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","volume":"34","author":"K Ubhi","year":"2011","unstructured":"Ubhi, K., Low, P. & Masliah, E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci. 34, 581\u2013590 (2011).","journal-title":"Trends Neurosci."},{"key":"346_CR82","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12031-013-0154-x","volume":"52","author":"K Pukass","year":"2014","unstructured":"Pukass, K. & Richter-Landsberg, C. Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular alpha-synuclein in oligodendrocytes. J. Mol. Neurosci. 52, 339\u2013352 (2014).","journal-title":"J. Mol. Neurosci."},{"key":"346_CR83","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.stemcr.2017.12.001","volume":"10","author":"S Kaji","year":"2018","unstructured":"Kaji, S. et al. Pathological endogenous alpha-synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Rep. 10, 356\u2013365 (2018).","journal-title":"Stem Cell Rep."},{"key":"346_CR84","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl Acad. Sci. USA 106, 13010\u201313015 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"346_CR85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00401-016-1572-y","volume":"132","author":"B Ettle","year":"2016","unstructured":"Ettle, B. et al. alpha-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy. Acta Neuropathol. 132, 59\u201375 (2016).","journal-title":"Acta Neuropathol."},{"key":"346_CR86","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner, S. B. et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl Acad. Sci. USA 112, E5308\u2013E5317 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"346_CR87","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00401-019-01959-4","volume":"137","author":"AL Woerman","year":"2019","unstructured":"Woerman, A. L. et al. Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines. Acta Neuropathol. 137, 437\u2013454 (2019).","journal-title":"Acta Neuropathol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0346-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:11Z","timestamp":1684617071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":87,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0346-8","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}